These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 31385095)

  • 1. Insight into the Dissolution Molecular Mechanism of Ternary Solid Dispersions by Combined Experiments and Molecular Simulations.
    Han R; Huang T; Liu X; Yin X; Li H; Lu J; Ji Y; Sun H; Ouyang D
    AAPS PharmSciTech; 2019 Aug; 20(7):274. PubMed ID: 31385095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation and in vivo hypoglycemic effect of glipizide solid dispersion.
    Patel GC; Asodaria KV; Patel HP; Shah DR
    Curr Drug Deliv; 2012 Jul; 9(4):395-404. PubMed ID: 22640037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation and characterization of glipizide solid dosage form with enhanced solubility.
    Alotaibi BS; Khan MA; Ullah K; Yasin H; Mannan A; Khan SA; Murtaza G
    PLoS One; 2024; 19(2):e0297467. PubMed ID: 38394326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and dissolution properties of ketoprofen in binary and ternary solid dispersions with polyethylene glycol and surfactants.
    Mura P; Moyano JR; González-Rodríguez ML; Rabasco-Alvaréz AM; Cirri M; Maestrelli F
    Drug Dev Ind Pharm; 2005 May; 31(4-5):425-34. PubMed ID: 16093208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thermal behavior and dissolution properties of naproxen from binary and ternary solid dispersions.
    Mura P; Faucci MT; Manderioli A; Bramanti G; Parrini P
    Drug Dev Ind Pharm; 1999 Mar; 25(3):257-64. PubMed ID: 10071817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solid carriers for improved solubility of glipizide in osmotically controlled oral drug delivery system.
    Mehramizi A; Alijani B; Pourfarzib M; Dorkoosh FA; Rafiee -Tehrani M
    Drug Dev Ind Pharm; 2007 Aug; 33(8):812-23. PubMed ID: 17729098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved dissolution of oleanolic acid with ternary solid dispersions.
    Liu L; Wang X
    AAPS PharmSciTech; 2007 Dec; 8(4):E113. PubMed ID: 18181534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Approach to Enhance Dissolution Rate of Tamoxifen Citrate.
    SreeHarsha N; Hiremath JG; Chilukuri S; Aitha RK; Al-Dhubiab BE; Venugopala KN; Alzahrani AM; Meravanige G
    Biomed Res Int; 2019; 2019():2161348. PubMed ID: 30800663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binary and ternary solid dispersions of an anticancer preclinical lead, IIIM-290: In vitro and in vivo studies.
    Kumar V; Mintoo MJ; Mondhe DM; Bharate SB; Vishwakarma RA; Bharate SS
    Int J Pharm; 2019 Oct; 570():118683. PubMed ID: 31513869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability.
    Shuai S; Yue S; Huang Q; Wang W; Yang J; Lan K; Ye L
    Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):413-22. PubMed ID: 25669445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fast-dissolving and high-drug-loaded, Fatty Acid-based self-emulsifying solid dispersions of diacerein.
    Aggarwal AK; Singh S
    PDA J Pharm Sci Technol; 2012; 66(3):201-13. PubMed ID: 22634586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-polymer miscibility, interactions, and precipitation inhibition studies for the development of amorphous solid dispersions for the poorly soluble anticancer drug flutamide.
    Trivino A; Gumireddy A; Meng F; Prasad D; Chauhan H
    Drug Dev Ind Pharm; 2019 Aug; 45(8):1277-1291. PubMed ID: 31111732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissolution improvement of high drug-loaded solid dispersion.
    Okonogi S; Puttipipatkhachorn S
    AAPS PharmSciTech; 2006 Jun; 7(2):E52. PubMed ID: 16796369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation, characterization and tableting of cilnidipine solid dispersions.
    Hu L; Song W; Niu F; Jiao K; Jia Z
    Pak J Pharm Sci; 2013 May; 26(3):629-36. PubMed ID: 23625441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of rofecoxib-polyethylene glycol 4000 solid dispersions and tablets based on solid dispersions.
    Liu C; Desai KG
    Pharm Dev Technol; 2005; 10(4):467-77. PubMed ID: 16370176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved Aqueous Solubility and Antihypercholesterolemic Activity of Ezetimibe on Formulating with Hydroxypropyl-β-Cyclodextrin and Hydrophilic Auxiliary Substances.
    Srivalli KM; Mishra B
    AAPS PharmSciTech; 2016 Apr; 17(2):272-83. PubMed ID: 26077622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Albendazole solid dispersions prepared using PEG6000 and Poloxamer188: formulation, characterization and
    Dong CL; Zheng SD; Liu YY; Cui WQ; Hao MQ; God'spower BO; Chen XY; Li YH
    Pharm Dev Technol; 2020 Nov; 25(9):1043-1052. PubMed ID: 32546042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of the Binary and Ternary Atorvastatin Solid Dispersions:
    Faraji E; Mohammadi M; Mahboobian MM
    Biomed Res Int; 2021; 2021():6644630. PubMed ID: 34527740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A New Extrudable Form of Hypromellose: AFFINISOL™ HPMC HME.
    Huang S; O'Donnell KP; Keen JM; Rickard MA; McGinity JW; Williams RO
    AAPS PharmSciTech; 2016 Feb; 17(1):106-19. PubMed ID: 26335416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and characterization of gliclazide-polyethylene glycol 4000 solid dispersions.
    Patil MP; Gaikwad NJ
    Acta Pharm; 2009 Mar; 59(1):57-65. PubMed ID: 19304558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.